Prostatic Neoplasms

Showing NaN - NaN of 17

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Glen Burnie (177Lu-rhPSMA-10.1 injection,

Recruiting
  • Prostate Cancer
  • +5 more
  • 177Lu-rhPSMA-10.1 injection
  • 18F-rhPSMA-7.3 injection
  • Glen Burnie, Maryland
  • +3 more
Feb 2, 2023

Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Matching (normal saline), Abiraterone)

Active, not recruiting
  • Prostatic Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • +3 more
  • Anchorage, Alaska
  • +163 more
Jan 18, 2023

Prostatic Tumors Trial in Worldwide (Apalutamide, Abiraterone acetate, Prednisone)

Active, not recruiting
  • Prostatic Neoplasms
  • Phoenix, Arizona
  • +183 more
Jan 17, 2023

Prostatic Tumors Trial in Worldwide (Pembrolizumab, Docetaxel, Prednisone)

Active, not recruiting
  • Prostatic Neoplasms
  • Pembrolizumab
  • +4 more
  • Mobile, Alabama
  • +214 more
Nov 24, 2022

Prostatic Tumors Trial in Worldwide (Pembrolizumab, Enzalutamide, Placebo)

Active, not recruiting
  • Prostatic Neoplasms
  • Pembrolizumab
  • +2 more
  • Mobile, Alabama
  • +257 more
Nov 22, 2022

Prostatic Tumors Trial in Worldwide (EPI-7386, Abiraterone Acetate, Prednisone or Prednisolone)

Suspended
  • Prostatic Neoplasms
  • Towson, Maryland
  • +3 more
Nov 3, 2022

Prostatic Tumors Trial in Worldwide (Pembrolizumab, Olaparib, Abiraterone acetate)

Active, not recruiting
  • Prostatic Neoplasms
  • Pembrolizumab
  • +4 more
  • Fullerton, California
  • +192 more
Oct 17, 2022

Prostatic Tumors Trial in Worldwide (Niraparib)

Active, not recruiting
  • Prostatic Neoplasms
  • Tucson, Arizona
  • +109 more
Aug 2, 2022

Prostatic Tumors, Adenocarcinoma Trial in United States (JNJ-69086420)

Recruiting
  • Prostatic Neoplasms
  • Adenocarcinoma
  • Duarte, California
  • +7 more
Aug 2, 2022

Prostatic Tumors Trial in United States (Radium-223 dichloride (Xofigo, BAY88-8223), Abiraterone acetate, Prednisone)

Completed
  • Prostatic Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • +3 more
  • Scottsdale, Arizona
  • +18 more
Jul 4, 2019

Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223))

Completed
  • Prostatic Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Scottsdale, Arizona
  • +67 more
Jun 30, 2019

Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Completed
  • Advanced Prostate Cancer
  • Prostatic Neoplasms
  • sipuleucel-T
  • Bessemer, Alabama
  • +332 more
Mar 5, 2019

Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223))

Completed
  • Prostatic Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • New Orleans, Louisiana
  • +15 more
Mar 23, 2018

Prostatic Tumors Trial in Worldwide (Placebo, Abiraterone acetate, Prednisone/prednisolone)

Completed
  • Prostatic Neoplasms
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +127 more
Apr 10, 2014

Prostatic Tumors Trial in Worldwide (Prednisone, sunitinib, Placebo)

Terminated
  • Prostatic Neoplasms
  • Decatur, Alabama
  • +204 more
Feb 5, 2013